232 related articles for article (PubMed ID: 30416500)
1. Immunoproteasome Inhibition Impairs T and B Cell Activation by Restraining ERK Signaling and Proteostasis.
Schmidt C; Berger T; Groettrup M; Basler M
Front Immunol; 2018; 9():2386. PubMed ID: 30416500
[TBL] [Abstract][Full Text] [Related]
2. ONX 0914 Lacks Selectivity for the Cardiac Immunoproteasome in CoxsackievirusB3 Myocarditis of NMRI Mice and Promotes Virus-Mediated Tissue Damage.
Neumaier HL; Harel S; Klingel K; Kaya Z; Heuser A; Kespohl M; Beling A
Cells; 2020 Apr; 9(5):. PubMed ID: 32354159
[No Abstract] [Full Text] [Related]
3. DUSP5 and DUSP6, two ERK specific phosphatases, are markers of a higher MAPK signaling activation in BRAF mutated thyroid cancers.
Buffet C; Hecale-Perlemoine K; Bricaire L; Dumont F; Baudry C; Tissier F; Bertherat J; Cochand-Priollet B; Raffin-Sanson ML; Cormier F; Groussin L
PLoS One; 2017; 12(9):e0184861. PubMed ID: 28910386
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis.
Basler M; Mundt S; Muchamuel T; Moll C; Jiang J; Groettrup M; Kirk CJ
EMBO Mol Med; 2014 Feb; 6(2):226-38. PubMed ID: 24399752
[TBL] [Abstract][Full Text] [Related]
5. No prolongation of skin allograft survival by immunoproteasome inhibition in mice.
Mundt S; Basler M; Sawitzki B; Groettrup M
Mol Immunol; 2017 Aug; 88():32-37. PubMed ID: 28582644
[TBL] [Abstract][Full Text] [Related]
6. Immunoproteasome inhibitor DPLG3 attenuates experimental colitis by restraining NF-κB activation.
Moallemian R; Rehman AU; Zhao N; Wang H; Chen H; Lin G; Ma X; Yu J
Biochem Pharmacol; 2020 Jul; 177():113964. PubMed ID: 32278007
[TBL] [Abstract][Full Text] [Related]
7. Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation.
Li J; Basler M; Alvarez G; Brunner T; Kirk CJ; Groettrup M
Kidney Int; 2018 Mar; 93(3):670-680. PubMed ID: 29229189
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the Immunoproteasome Subunit LMP7 with ONX 0914 Ameliorates Graft-versus-Host Disease in an MHC-Matched Minor Histocompatibility Antigen-Disparate Murine Model.
Zilberberg J; Matos J; Dziopa E; Dziopa L; Yang Z; Kirk CJ; Assefnia S; Korngold R
Biol Blood Marrow Transplant; 2015 Sep; 21(9):1555-64. PubMed ID: 26093043
[TBL] [Abstract][Full Text] [Related]
9. Immunoproteasome inhibition induces plasma cell apoptosis and preserves kidney allografts by activating the unfolded protein response and suppressing plasma cell survival factors.
Li J; Koerner J; Basler M; Brunner T; Kirk CJ; Groettrup M
Kidney Int; 2019 Mar; 95(3):611-623. PubMed ID: 30685098
[TBL] [Abstract][Full Text] [Related]
10. Mitigated viral myocarditis in A/J mice by the immunoproteasome inhibitor ONX 0914 depends on inhibition of systemic inflammatory responses in CoxsackievirusB3 infection.
Goetzke CC; Althof N; Neumaier HL; Heuser A; Kaya Z; Kespohl M; Klingel K; Beling A
Basic Res Cardiol; 2021 Feb; 116(1):7. PubMed ID: 33523326
[TBL] [Abstract][Full Text] [Related]
11. Immunoproteasome Activity and Content Determine Hematopoietic Cell Sensitivity to ONX-0914 and to the Infection of Cells with Lentiviruses.
Vagapova E; Burov A; Spasskaya D; Lebedev T; Astakhova T; Spirin P; Prassolov V; Karpov V; Morozov A
Cells; 2021 May; 10(5):. PubMed ID: 34066177
[TBL] [Abstract][Full Text] [Related]
12. Immunoproteasome subunit LMP7 deficiency and inhibition suppresses Th1 and Th17 but enhances regulatory T cell differentiation.
Kalim KW; Basler M; Kirk CJ; Groettrup M
J Immunol; 2012 Oct; 189(8):4182-93. PubMed ID: 22984077
[TBL] [Abstract][Full Text] [Related]
13. Co-Inhibition of the Immunoproteasome Subunits LMP2 and LMP7 Ameliorates Immune Thrombocytopenia.
Du SH; Xiang YJ; Liu L; Nie M; Hou Y; Wang L; Li BB; Xu M; Teng QL; Peng J; Hou M; Shi Y
Front Immunol; 2020; 11():603278. PubMed ID: 33552061
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of dual-specificity phosphatase 6, a negative regulator of oncogenic ERK signaling, by ACA-28 induces apoptosis in NIH/3T3 cells overexpressing HER2/ErbB2.
Kanda Y; Mizuno A; Takasaki T; Satoh R; Hagihara K; Masuko T; Endo Y; Tanabe G; Sugiura R
Genes Cells; 2021 Feb; 26(2):109-116. PubMed ID: 33249692
[TBL] [Abstract][Full Text] [Related]
15. Immunoproteasome inhibition prevents progression of castration-resistant prostate cancer.
Li J; Liu N; Zhou H; Xian P; Song Y; Tang X; Li Y; Basler M
Br J Cancer; 2023 Mar; 128(7):1377-1390. PubMed ID: 36681728
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis induced by trimethyltin chloride in human neuroblastoma cells SY5Y is regulated by a balance and cross-talk between NF-κB and MAPKs signaling pathways.
Qing Y; Liang Y; Du Q; Fan P; Xu H; Xu Y; Shi N
Arch Toxicol; 2013 Jul; 87(7):1273-85. PubMed ID: 23423712
[TBL] [Abstract][Full Text] [Related]
17. A patent review of immunoproteasome inhibitors.
Ogorevc E; Schiffrer ES; Sosič I; Gobec S
Expert Opin Ther Pat; 2018 Jul; 28(7):517-540. PubMed ID: 29865878
[TBL] [Abstract][Full Text] [Related]
18. Immunoproteasome Inhibition Selectively Kills Human CD14
Basler M; Claus M; Klawitter M; Goebel H; Groettrup M
J Immunol; 2019 Oct; 203(7):1776-1785. PubMed ID: 31484727
[TBL] [Abstract][Full Text] [Related]
19. The mammalian target of rapamycin modulates the immunoproteasome system in the heart.
Zhang HM; Fu J; Hamilton R; Diaz V; Zhang Y
J Mol Cell Cardiol; 2015 Sep; 86():158-67. PubMed ID: 26239133
[TBL] [Abstract][Full Text] [Related]
20. Structure of human immunoproteasome with a reversible and noncompetitive inhibitor that selectively inhibits activated lymphocytes.
Santos RLA; Bai L; Singh PK; Murakami N; Fan H; Zhan W; Zhu Y; Jiang X; Zhang K; Assker JP; Nathan CF; Li H; Azzi J; Lin G
Nat Commun; 2017 Nov; 8(1):1692. PubMed ID: 29167449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
